|
1
|
Watanabe H, Enjoji M and Imai T: Gastric
carcinoma with lymphoid stroma. Histopathology. Cancer. 38:232–243.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burke AP, Yen TS, Shekitka KM and Sobin
LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr
virus demonstrated by polymerase chain reaction. Mod Pathol.
3:377–380. 1990.PubMed/NCBI
|
|
3
|
Shinozaki-Ushiku A, Kunita A and Fukayama
M: Update on Epstein-Barr virus and gastric cancer (Review). Int J
Oncol. 46:1421–1434. 2015.PubMed/NCBI
|
|
4
|
Cheng N, Hui DY, Liu Y, Zhang NN, Jiang Y,
Han J, Li HG, Ding YG, Du H, Chen JN and Shao CK: Is gastric
lymphoepithelioma-like carcinoma a special subtype of
EBV-associated gastric carcinoma? New insight based on
clinicopathological features and EBV genome polymorphisms. Gastric
Cancer. 18:246–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fukayama M and Ushiku T: Epstein-Barr
virus-associated gastric carcinoma. Pathol Res Pract. 207:529–537.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grogg KL, Lohse CM, Pankratz VS, Halling
KC and Smyrk TC: Lymphocyte-rich gastric cancer, Associations with
Epstein-Barr virus, microsatellite instability, histology, and
survival. Mod Pathol. 16:641–651. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bittar Z, Fend F and Quintanilla-Martinez
L: Lymphoepithelioma-like carcinoma of the stomach A case report
and review of the literature. Diagn Pathol. 8:1842013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fukayama M: Epstein-Barr virus and gastric
carcinoma. Jpn J Clin Med. 70:1715–1719. 2012.(In Japanese).
|
|
9
|
Chen JN, He D, Tang F and Shao CK:
Epstein-Barr virus-associated gastric carcinoma, A newly defined
entity. J Clin Gastroenterol. 46:262–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murphy G, Pfeiffer R, Camargo MC and
Rabkin CS: Meta-analysis shows that prevalence of Epstein-Barr
virus-positive gastric cancer differs based on sex and anatomic
location. Gastroenterology. 137:824–833. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee JH, Kim SH, Han SH, An JS, Lee ES and
Kim YS: Clinicopathological and molecular characteristics of
Epstein-Barr virus-associated gastric carcinoma, A meta-analysis. J
Gastroenterol Hepatol. 24:354–365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maeda E, Akahane M, Uozaki H, Kato N,
Hayashi N, Fukayama M and Ohtomo K: CT appearance of Epstein-Barr
virus-associated gastric carcinoma. Abdom Imaging. 34:618–625.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai Y, Gao Q, Ren G, Wang B and Xiang H:
Epstein-Barr virus-associated lymphoepithelioma-like gastric
carcinoma located on gastric high body, Two case reports. Indian J
Pathol Microbiol. 57:463–466. 2014.PubMed/NCBI
|
|
15
|
Uozaki H and Fukayama M: Epstein-Barr
virus and gastric carcinoma - viral carcinogenesis through
epigenetic mechanisms. Int J Clin Exp Pathol. 1:198–216.
2008.PubMed/NCBI
|
|
16
|
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox
JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, et al:
Bortezomib-induced enzyme-targeted radiation therapy in
herpesvirus-associated tumors. Nat Med. 14:1118–1122. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung EJ, Lee YM, Lee BL, Chang MS and Kim
WH: Lytic induction and apoptosis of Epstein-Barr virus-associated
gastric cancer cell line with epigenetic modifiers and ganciclovir.
Cancer Lett. 247:77–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stevanović S, Draper LM, Langhan MM,
Campbell TE, Kwong ML, Wunderlich JR, Dudley ME, Yang JC, Sherry
RM, Kammula US, et al: Complete regression of metastatic cervical
cancer after treatment with human papillomavirus-targeted
tumor-infiltrating T cells. J Clin Oncol. 33:1543–1550. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dolan DE and Gupta S: PD-1 pathway
inhibitors: Changing the landscape of cancer immunotherapy. Cancer
Control. 21:231–237. 2014.PubMed/NCBI
|
|
20
|
Naidoo J, Page DB and Wolchok JD: Immune
modulation for cancer therapy. Br J Cancer. 111:2214–2219. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim SY, Park C, Kim HJ, Park J, Hwang J,
Kim JI, Choi MG, Kim S, Kim KM and Kang MS: Deregulation of immune
response genes in patients with Epstein-Barr virus-associated
gastric cancer and outcomes. Gastroenterology. 148:137–147.e9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tak DH, Jeong HY, Seong JK, Moon HS and
Kang SH: Comparison of clinical characteristics and prognostic
factors between gastric lymphoepithelioma-like carcinoma and
gastric adenocarcinoma. Korean J Gastroenterol. 62:272–277.
2013.(In Korean). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park S, Choi MG, Kim KM, Kim HS, Jung SH,
Lee JH, Noh JH, Sohn TS, Bae JM and Kim S: Lymphoepithelioma-like
carcinoma, A distinct type of gastric cancer. J Surg Res.
194:458–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim KH, Kim MC, Jung GJ and Kim SJ: The
differences in clinicopathological features and prognosis among the
subtypes of signet ring cell, mucinous, papillary, and
lymphoepithelioma-like carcinoma in advanced gastric cancer.
Hepatogastroenterology. 61:2149–2155. 2014.PubMed/NCBI
|
